Skip to main navigation
  • About
    • About
    • Management
    • Directors
    • Advisors
    • History
  • Programs
    • Pipeline
      • Alport Syndrome
      • ADPKD
  • Platform
    • About microRNAs
    • Platform Technology
    • Biology & Pharmacology
    • Intellectual Property
  • News
  • Publications
  • Investors

    Investor Relations

    • Overview
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
      • Form 8937
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
      • Quarterly Results
    • Press Releases
    • Events & Presentations
    • Investor FAQs
    • Contact Us
  • Careers
    • Working at Regulus
    • Current Openings
    • Internships
    • Benefits
      • Keeping our RGLS Family Healthy
      • Compensation and Financial Rewards
      • Time to Recharge
    • In the Community
  • Contact
y=0
x=80

Regulus Therapeutics

Search
Skip to content
  • About
    • About
    • Management
    • Directors
    • Advisors
    • History
  • Programs
    • Pipeline
      • Alport Syndrome
      • ADPKD
  • Platform
    • About microRNAs
    • Platform Technology
    • Biology & Pharmacology
    • Intellectual Property
  • News
  • Publications
  • Investors

    Investor Relations

    • Overview
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
      • Ownership Profile
      • Form 8937
    • Corporate Governance
      • Management
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
      • Quarterly Results
    • Press Releases
    • Events & Presentations
    • Investor FAQs
    • Contact Us
  • Careers
    • Working at Regulus
    • Current Openings
    • Internships
    • Benefits
      • Keeping our RGLS Family Healthy
      • Compensation and Financial Rewards
      • Time to Recharge
    • In the Community
  • Contact

Shareholder Tools

Email Alerts
RSS
Printed Materials
Print this page
 

Achieve

FINANCIALS & FILINGS

Show all

2018

Q4
  • Regulus Reports Fourth Quarter and Year-End 2018 Financial Results and Recent Updates
  • Form 10-K
  • Form 10-K/A

Annual Reports

Title View

Proxy Statement

  • Add Files
    Proxy Statement 946.5 KB

Proxy Statements

Filing date View
Apr 29, 2020 View HTML
0001193125-20-124163.pdf
0001193125-20-124163.rtf
0001193125-20-124163.xls
Jul 01, 2019 View HTML
0001193125-19-186518.pdf
0001193125-19-186518.rtf
0001193125-19-186518.xls

Form 10-K

Filing date View
Mar 12, 2020 View HTML
0001628280-20-003483.pdf
0001628280-20-003483.rtf
0001628280-20-003483.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
Mar 18, 2019 View HTML
0001628280-19-003037.pdf
0001628280-19-003037.rtf
0001628280-19-003037.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Form 10-Q

Filing date View
Nov 05, 2020 View HTML
0001628280-20-015789.pdf
0001628280-20-015789.rtf
0001628280-20-015789.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 13, 2020 View HTML
0001628280-20-012643.pdf
0001628280-20-012643.rtf
0001628280-20-012643.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
© 2021 Regulus Therapeutics Inc. - All Rights Reserved Home | Legal | Contact
MENU